BRD9

BRD9
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesBRD9, LAVS3040, PRO9856, bromodomain containing 9
External IDsOMIM: 618465; MGI: 2145317; HomoloGene: 82462; GeneCards: BRD9; OMA:BRD9 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

65980

105246

Ensembl

ENSG00000028310

ENSMUSG00000057649

UniProt

Q9H8M2

Q3UQU0

RefSeq (mRNA)

NM_001009877
NM_023924
NM_001317951

NM_001024508
NM_001308041
NM_001378947
NM_001378948

RefSeq (protein)

NP_001019679
NP_001294970
NP_001365876
NP_001365877

Location (UCSC)Chr 5: 0.85 – 0.89 MbChr 13: 73.94 – 73.96 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Bromodomain-containing protein 9 is a protein that in humans is encoded by the BRD9 gene. [5]

Structure and interaction

BRD9 contains a bromodomain. It is closely related to BRD7. BRD9 is present in some SWI/SNF ATPase remodeling complexes.[6]

Role in cancer

The BRD9 gene is frequently present in variable copy number in lung cancer.[7]

Small molecule inhibition

Small molecules capable of binding to the bromodomain of BRD9 have been developed.[8][9][10]

See also

Bromodomain

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000028310Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000057649Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: Bromodomain containing 9".
  6. ^ Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. (June 2013). "Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy". Nature Genetics. 45 (6): 592–601. doi:10.1038/ng.2628. PMC 3667980. PMID 23644491.
  7. ^ Kang JU, Koo SH, Kwon KC, Park JW, Kim JM (April 2008). "Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer". Cancer Genetics and Cytogenetics. 182 (1): 1–11. doi:10.1016/j.cancergencyto.2007.12.004. PMID 18328944.
  8. ^ Fedorov O, Lingard H, Wells C, Monteiro OP, Picaud S, Keates T, et al. (January 2014). "[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains". Journal of Medicinal Chemistry. 57 (2): 462–476. doi:10.1021/jm401568s. PMC 3906316. PMID 24313754.
  9. ^ Clark PG, Vieira LC, Tallant C, Fedorov O, Singleton DC, Rogers CM, et al. (May 2015). "LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor". Angewandte Chemie. 54 (21): 6217–6221. Bibcode:2015ACIE...54.6217C. doi:10.1002/anie.201501394. PMC 4449114. PMID 25864491.
  10. ^ Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, et al. (February 2016). "Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition". Journal of Medicinal Chemistry. 59 (4): 1425–1439. doi:10.1021/acs.jmedchem.5b00256. PMC 7354103. PMID 25856009.